Rocket Lab USA (RKLB)
(Delayed Data from NSDQ)
$4.00 USD
+0.05 (1.27%)
Updated May 3, 2024 04:00 PM ET
After-Market: $4.00 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth D Momentum F VGM
Income Statements
Fiscal Year end for Rocket Lab USA, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 245 | 211 | 62 | 0 | NA |
Cost Of Goods | 193 | 192 | 64 | 0 | NA |
Gross Profit | 51 | 19 | -2 | 0 | NA |
Selling & Adminstrative & Depr. & Amort Expenses | 229 | 154 | 100 | 0 | 0 |
Income After Depreciation & Amortization | -178 | -135 | -102 | 0 | 0 |
Non-Operating Income | 3 | 10 | -17 | 0 | NA |
Interest Expense | 4 | 8 | 6 | 0 | NA |
Pretax Income | -179 | -133 | -125 | 0 | NA |
Income Taxes | 4 | 3 | -8 | 0 | NA |
Minority Interest | 0 | 0 | 0 | 0 | NA |
Investment Gains/Losses | 0 | 0 | 0 | 0 | NA |
Other Income/Charges | 0 | 0 | 0 | 0 | NA |
Income From Cont. Operations | -183 | -136 | -117 | 0 | NA |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | NA |
Net Income (GAAP) | -183 | -136 | -117 | 0 | NA |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -145 | -102 | -89 | 0 | 0 |
Depreciation & Amortization (Cash Flow) | 33 | 33 | 13 | 0 | NA |
Income After Depreciation & Amortization | -178 | -135 | -102 | 0 | 0 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 481.77 | 466.21 | 209.90 | NA | NA |
Diluted EPS Before Non-Recurring Items | -0.38 | -0.29 | -0.56 | NA | NA |
Diluted Net EPS (GAAP) | -0.38 | -0.29 | -0.56 | -0.05 | NA |
Fiscal Year end for Rocket Lab USA, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 59.99 | 67.66 | 62.05 | 54.90 |
Cost Of Goods | NA | 44.50 | 52.69 | 47.45 | 48.54 |
Gross Profit | NA | 15.49 | 14.97 | 14.59 | 6.36 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 63.38 | 53.83 | 59.76 | 52.38 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -47.89 | -38.86 | -45.17 | -46.02 |
Non-Operating Income | NA | -0.20 | 1.06 | 0.78 | 1.61 |
Interest Expense | NA | 1.41 | 1.41 | 0.75 | 0.69 |
Pretax Income | NA | -49.49 | -39.22 | -45.13 | -45.09 |
Income Taxes | NA | 1.01 | 1.35 | 0.76 | 0.53 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -50.50 | -40.57 | -45.89 | -45.62 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -50.50 | -40.57 | -45.89 | -45.62 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 486.96 | 484.03 | 479.74 | 476.20 |
Diluted EPS Before Non-Recurring Items | NA | -0.10 | -0.08 | -0.10 | -0.10 |
Diluted Net EPS (GAAP) | NA | -0.10 | -0.08 | -0.10 | -0.10 |